Veterinary Services group, CVS, (AIM: CVSG) joined AIM today after placing approximately 45.2 million shares at 205 pence per with new investors. The placing represented 87.7% of the issued capital - the shares were supplied by Nash Sells Partnership II, a fund managed by Sovereign Capital Partners which has controlled CVS privately for 8 years.
CVS comprises of 45 small animal practices, a equine specialist practice and three veterinary diagnostic laboratories.
Simon Innes, Chief Executive of CVS, added:
"The company's admission to the London AIM market and commencement of dealings is a significant step for CVS. Our business has been built by a strong team of dedicated professionals who ensure both quality and reputation result in CVS being highly regarded within the sector.
Becoming a public company is a natural progression for us raising our corporate profile and securing our continued success in both acquisitive and organic growth."